The FDA has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio in vitro diagnostic (IVD ...

Implantable lens developer STAAR will fund the repurchase using cash on hand and money generated from business operations.

GE HealthCare has gained 501(k) clearance from the US Food and Drug Administration (FDA) for its CleaRecon DL technology.

Ophthalmic technology developer Intalight has received the CE mark for its DREAM OCT (optical coherence tomography) platform ...

A new AI model will be trained on a large set of NHS data in hopes of identifying early interventions for patient care.

Abbott's REFLECT studies indicate that FreeStyle Libre use is linked to a decrease in hospitalisation risk for heart ...

Between 2022 and 2027, leading data and analytics company GlobalData forecasts show cybersecurity spending by healthcare ...

The FDA has granted breakthrough device designation for Elucent Medical’s EnVisio X1 In-Body Spatial Intelligence System.

The Final Rule was mooted for implementation over a staged transition period, determined by a service’s risk level, by 2028.

A new report by Royal Philips warns that the ‘trust gap’ around deploying artificial intelligence (AI) in healthcare systems ...

New research has revealed that UK adults feel "let down" by mental health services provided by the UK's National Health ...

The US Food and Drug Administration (FDA) has granted approval for Roche's VENTANA MET (SP44) RxDx Assay for NSQ-NSCLC.